Bacitracin 500 U/g Ointment, 30 g
by RUGBY LABORATORIES · 30 g in 1 BOX (0536-1256-28)
NDC 00536-1256-28
🏷️ FDA NDC (as labeled)
0536-1256-28
billing pads the labeler segment with a zero
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
0536-1256-28
Product NDC
0536-1256
11-digit billing NDC
00536125628
NCPDP billing unit
GM — per gram (weight)
RxCUI
1648110
UNII
58H6RWO52I
UPC
0305361256289
Application #
M004
SPL Set ID
aa9f414e-d8de-417d-9ccd-027d5a5f5499
Physiologic effect
Decreased Cell Wall Synthesis & Repair
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2020-04-30
Route
TOPICAL
Dosage form
OINTMENT
Substance
BACITRACIN
GPI-14
90100010004210
GPI class
Bacitracin
GCN Seq No
007731
GCN
31812
HICL code
004047
Ingredient (HICL)
Bacitracin
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q5
Therapeutic class — intermediate (HIC2)
Agents Acting Principally On The Skin
HIC3 code
Q5W
Therapeutic class — specific (HIC3)
Topical Antibiotics
AHFS code
84:04.04.00
AHFS class
Antibacterials (84:04)
FDB label name
BACITRACIN 500 UNIT/GM OINTMNT
FDB brand name
Bacitracin
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 0536-1256-28 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1256-28. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Other antibiotics for topical use class.
Drug family (ATC)
Other antibiotics for topical use, Other antibacterials, Antibiotics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerRUGBY LABORATORIES
FDA applicationM004 (OTC MONOGRAPH DRUG)
Labeler code00536
First marketedApr 2020
Product typeHuman Otc Drug
Portfolio149 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name BACITRACIN 500 UNIT/GM OINTMNT Ingredient Bacitracin
📖 What it is MedlinePlus · NLM
Bacitracin is used to help prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Bacitracin is in a class of medications called antibiotics. Bacitracin works by stopping the growth of bacteria.
Read the full MedlinePlus article ↗📗 Our plain-language guide HelloPharmacist
- It's a first aid antibiotic you put directly on the skin to help prevent infection in minor cuts, scrapes, and burns. It's not meant for serious or deep wounds — just everyday smal...
- What exactly is bacitracin topical used for?
- Use a small amount — about the size of the tip of your finger — and apply it to the clean, dry area 1 to 3 times a day. You can put a sterile bandage over it if you like. Don't use...
- Not without checking with your doctor first. Bacitracin topical is meant for minor wounds. Deep or puncture wounds, animal bites, and serious burns need a doctor's evaluation — thi...
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Bacitracin — tap one for details:
7
Nutrient depletion considerations
Bacitracin may be associated with lower levels of 7 nutrients — worth a chat with your pharmacist, not a cause for alarm.
BIOTIN
Insignificant Depletion
FOLIC ACID
Insignificant Depletion
RIBOFLAVIN
Insignificant Depletion
THIAMINE
Insignificant Depletion
VITAMIN B12
Insignificant Depletion
+2 more
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about BACITRACIN?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII N6K5787QVP
Light mineral oil is a clear, odorless liquid derived from petroleum. In medicines, it acts as a lubricant and emollient to help the product spread smoothly and improve texture.
-
UNII 4T6H12BN9U
Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.
2 inactive ingredients listed in the exact product block matched to this NDC.
The official label also stateslight mineral oil, white petrolatum
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.054 | $1.62 / 30 g |
| Medicaid paysCMS SDUD · 12 mo | $0.4048 | $12.14 / 30 g |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per g) — tap or hover for the price & month
▼ Down 11% over the last 13 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Bacitracin 500 U/gthis 00536-1256-28 | RUGBY | 30 g | $0.054 | — | Availability likely | — |
| Bacitracin 500 [USP'U]/g 00713-0280-31 | Cosette | 28.4 g | $0.074 | — | Availability likely | +37% |
| Bacitracin 500 [iU]/g 68001-0477-46 | BluePoint | 1 tube | $0.094 | — | Availability likely | +74% |
| Bacitracin 500 [USP'U]/g 45802-0060-01 | Padagis | 1 tube | $0.114 | — | Availability likely | +111% |
| Major Bacitracin 500 [USP'U]/g 00904-7402-67 | Major | 144 packets | $0.121 | — | FDA listed | +124% |
| signature care first aid antibiotic 500 [USP'U]/g 21130-0757-64 | Safeway | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 30142-0536-64 | Kroger | 1 tube | — | — | FDA listed | — |
| Antibiotic 500 [USP'U]/g 36800-0536-64 | Topco | 1 tube | — | — | FDA listed | — |
| bacitracin 500 [USP'U]/g 37808-0536-64 | H | 1 tube | — | — | FDA listed | — |
| MediChoice Bacitracin 500 [iU]/g 39892-0810-01 | O&M | 144 packets | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 41226-0880-02 | Kroger | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 41250-0844-64 | Meijer | 1 tube | — | — | FDA listed | — |
| first aid antibiotic 500 [USP'U]/g 42507-0536-64 | HyVee | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 50090-0815-00 | A-S | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 50090-0845-00 | A-S | 144 packets | — | — | FDA listed | — |
| Rexall Antibiotic 500 [USP'U]/g 55910-0536-64 | Dolgencorp, | 1 tube | — | — | FDA listed | — |
| Publix Bacitracin Zinc 500 [USP'U]/g 56062-0815-28 | PUBLIX | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 59779-0536-64 | CVS | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [iU]/g 63187-0299-01 | Proficient | 28.35 g | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/1000mg 67777-0116-10 | Dynarex | 144 packets | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 68071-5253-03 | NuCare | 28.4 g | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 68788-8643-02 | Preferred | 28.4 g | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 68788-9794-02 | Preferred | 28 g | — | — | FDA listed | — |
| TheraCare Bacitracin Zinc 500 [USP'U]/g 71101-0019-01 | Veridian | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 71205-0057-01 | Proficient | 28.4 g | — | — | FDA listed | — |
| Vitastem Ultra First Aid Antibiotic 500 U/g 71262-0013-15 | Viaderma | 1 bottle | — | — | FDA listed | — |
| Viaderma Care First Aid 500 U/g 71262-0015-15 | ViaDerma | 1 bottle | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 71335-2731-01 | Bryant | 144 packets | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 72162-2280-02 | Bryant | 144 packets | — | — | FDA listed | — |
| astonea First Aid 500 [USP'U]/g 77338-0303-52 | ASTONEA | 9 g | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 84387-0002-01 | ALLIED | 28.4 g | — | — | FDA listed | — |
| Bacitracin 500 [iU]/g 87236-0000-01 | AlderMed | 1 tube | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2020
On the market since
Apr 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00536-1256-28, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
25.3K
Units reimbursed last 4 qtrs
840K
Gross reimbursed last 4 qtrs
$340K
Avg / prescription
$13.44
Avg / unit
$0.4048
Latest quarter Q4 2025
5.2KRx
Medicaid pays / g
$0.4048
gross reimbursed
vs
NADAC / g
$0.0539
acquisition cost
=
Spread
+$0.3509
+651% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 16,730 Rx Managed care · 8,574 Rx
State Medicaid map
Units reimbursed · per 100k residents
6.3924
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Bacitracin — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Bacitracin. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$3.9K
Claims incl. refills
44
Beneficiaries
42
Spend / beneficiary
$92.36
Spend / claim
$88.16
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Bacitracin — the ingredient across all brands.
Top reported reactions
Reporter sex
Male · 38%
Female · 62%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 00536-1256-28 You're viewing this | 30 g in 1 BOX (0536-1256-28) | 2020-04-30 | Active |
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses first aid to help prevent infection in: minor cuts scrapes burns
⏱️ Dosage and Administration ▾
Directions clean the affected area apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily may be covered with a sterile bandage
⚠️ Warnings ▾
Warnings For external use only. Do not use in the eyes on large areas of the body if you are allergic to any of the ingredients Ask a doctor before use if you have deep or puncture wounds animal bites serious burns Stop use and ask a doctor if you need to use longer than 1 week condition persists or gets worse rash or other allergic reaction develops Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center(1-800-222-1222) right away.
🧪 Active Ingredient ▾
Active ingredients (in each gram) Bacitracin 500 units Purpose First aid antibiotic
🧪 Inactive Ingredients ▾
Inactive ingredients light mineral oil, white petrolatum
🎯 Purpose ▾
Purpose First aid antibiotic
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.